X
    X
    X
    X

    Edwards Wildman Advises CoreLabs and Ampersand Capital Partners in Two-Step Acquisition, Reports The Deal

    News

     

    Private equity firms Ampersand Capital Partners and JLL Partners Inc. have announced that they will acquire clinical trial management services company BioClinica Inc. (Nasdaq: BIOC) and medical imaging and cardiac safety services provider CoreLab Partners Inc., reported The Deal. The article, "JLL Partners Makes Two-Step Bid for BioClinica, CoreLab," stated that Princeton, N.J.-based CoreLabs was established in 2010 after the merger of Ampersand Capital Partners-backed RadPharm Inc., an imaging laboratory, and Medifacts International Inc., a cardiovascular laboratory. The company that will result from the merger of CoreLabs and BioClinica will be owned jointly by JLL and Ampersand, CoreLabs' majority owner. Edwards Wildman advised CoreLabs and Ampersand Capital Partners in the transaction. The deal team consisted of Stan Keller, David Szabo and Ben Ferrucci in the firm's Boston office and Joe Farside in the firm's Providence office.

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.